Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Lumicell, Inc.

Lumicell, Inc.

Stage unknownNewton, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
3 rounds
  1. Apr 22, 2025
    Form D equity offering · $198M (form d sold) · 64 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Lumicell, Inc. filed Form D: $198,128,718 sold (indefinite offering), Biotechnology
  2. Jul 11, 2024
    Form D equity offering · $2.7M (form d sold) · 11 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Lumicell, Inc. filed Form D: $2,730,612 sold of $12,000,000, Biotechnology
  3. Feb 22, 2024
    Form D equity offering · $2.3M (form d sold) · 6 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Lumicell, Inc. filed Form D: $2,275,000 sold (indefinite offering), Biotechnology
Investors on record
1 edges
People
3 officers, 13 directors
Timeline
3
  1. May 6, 2025
    Lumicell, Inc. filed Form D: $198,128,718 sold (indefinite offering), Biotechnology
  2. Jul 25, 2024
    Lumicell, Inc. filed Form D: $2,730,612 sold of $12,000,000, Biotechnology
  3. Mar 8, 2024
    Lumicell, Inc. filed Form D: $2,275,000 sold (indefinite offering), Biotechnology
Evidence
42 observations
Every observation on this company